Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6304-56-9

Post Buying Request

6304-56-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6304-56-9 Usage

Description

1-CYCLOHEXYL-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID, commonly known as L-proline, is a naturally occurring amino acid that plays a crucial role in the human body. It is an essential component of the diet, involved in the synthesis of proteins and enzymes. L-proline is a key building block for collagen, the most abundant protein in the human body, and an important structural component of connective tissues, skin, and bones. It has been studied for its potential health benefits, including supporting cardiovascular health and promoting healthy skin and joint function. L-proline is commonly used as a dietary supplement and can be found in various foods such as meat, dairy, and legumes.

Uses

Used in Nutritional Supplements:
1-CYCLOHEXYL-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID is used as a dietary supplement for its essential role in protein synthesis and its potential health benefits, including supporting cardiovascular health and promoting healthy skin and joint function.
Used in Food Industry:
1-CYCLOHEXYL-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID is used as a natural amino acid in various foods, including meat, dairy, and legumes, to enhance their nutritional value and support the synthesis of proteins and enzymes.
Used in Pharmaceutical Industry:
1-CYCLOHEXYL-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID is used as a key building block for collagen, which is an important structural component of connective tissues, skin, and bones. It is utilized in the development of pharmaceutical products targeting skin health, joint function, and connective tissue support.
Used in Cosmetics Industry:
1-CYCLOHEXYL-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID is used as an ingredient in cosmetic products for its potential benefits in promoting healthy skin and supporting collagen synthesis, contributing to skin elasticity and hydration.

Check Digit Verification of cas no

The CAS Registry Mumber 6304-56-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,0 and 4 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 6304-56:
(6*6)+(5*3)+(4*0)+(3*4)+(2*5)+(1*6)=79
79 % 10 = 9
So 6304-56-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H17NO3/c13-10-6-8(11(14)15)7-12(10)9-4-2-1-3-5-9/h8-9H,1-7H2,(H,14,15)/p-1/t8-/m1/s1

6304-56-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-cyclohexyl-5-oxopyrrolidine-3-carboxylic acid

1.2 Other means of identification

Product number -
Other names 1-cyclohexyl-5-oxo-3-pyrrolidinecarboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6304-56-9 SDS

6304-56-9Relevant articles and documents

PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS

-

Page/Page column 42, (2016/06/01)

Simple organic structures, organic/inorganic polymers, and other substrates have been made, all of which have at least one pyrrolidone moiety present, and found to exhibit low toxicity, low complement activation features and may be used to reduce protein

INDOLE AMIDE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES

-

Page/Page column 161, (2010/12/29)

This invention provides novel compounds and the novel compounds for use as a medicine, more in particular for the prevention or treatment of neurodegenerative disorders, more specifically certain neurological disorders, such as disorders collectively known as tauopathies, and disorders characterised by cytotoxic α-synuclein amyloidogenesis. The present invention also relates to the use of said novel compounds for the manufacture of medicaments useful for treating such neurodegenerative disorders. The present invention further relates to pharmaceutical compositions including said novel compounds and to methods for the preparation of said novel compounds.

Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis

He, Xin,Alian, Akram,Stroud, Robert,Ortiz De Montellano, Paul R.

, p. 6308 - 6323 (2007/10/03)

In view of the worldwide spread of multidrug resistance of Mycobacterium tuberculosis, there is an urgent need to discover antituberculosis agent with novel structures. InhA, the enoyl acyl carrier protein reductase (ENR) from M. tuberculosis, is one of t

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6304-56-9